Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma

NCT01389414 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Biliary Carcinoma

Interventions

DRUG: Panitumumab plus GEMOX chemotherapy
DRUG: GEMOX chemotherapy

Sponsor

Prof. Massimo Aglietta